{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:24:00Z","timestamp":1793910240575,"version":"4.8.0"},"reference-count":160,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160364"],"award-info":[{"award-number":["82160364"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Project of the Jiangxi Provincial Department of Science and Technology","award":["20202ACBL206007"],"award-info":[{"award-number":["20202ACBL206007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s12035-023-03870-2","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T03:02:16Z","timestamp":1702954936000},"page":"4677-4690","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The Role of Iron Metabolism in Sepsis-associated Encephalopathy: a Potential Target"],"prefix":"10.1007","volume":"61","author":[{"given":"Yinuo","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengliang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1387-524X","authenticated-orcid":false,"given":"Xiaohong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,19]]},"reference":[{"issue":"6","key":"3870_CR1","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1007\/s10753-021-01501-3","volume":"44","author":"Q Gao","year":"2021","unstructured":"Gao Q, Hernandes MS (2021) Sepsis-associated encephalopathy and blood-brain barrier dysfunction. Inflammation 44(6):2143\u20132150","journal-title":"Inflammation"},{"issue":"10","key":"3870_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nrneurol.2012.183","volume":"8","author":"TE Gofton","year":"2012","unstructured":"Gofton TE, Young GB (2012) Sepsis-associated encephalopathy. Nat Rev Neurol 8(10):557\u2013566","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"3870_CR3","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s13311-020-00862-1","volume":"17","author":"A Mazeraud","year":"2020","unstructured":"Mazeraud A, Righy C, Bouchereau E, Benghanem S, Bozza FA, Sharshar T (2020) Septic-associated encephalopathy: a comprehensive review. Neurotherapeutics 17(2):392\u2013403","journal-title":"Neurotherapeutics"},{"issue":"3","key":"3870_CR4","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3390\/jcm9030703","volume":"9","author":"HY Chung","year":"2020","unstructured":"Chung HY, Wickel J, Brunkhorst FM, Geis C (2020) Sepsis-associated encephalopathy: from delirium to dementia? J Clin Med 9(3):703","journal-title":"J Clin Med"},{"key":"3870_CR5","doi-asserted-by":"publisher","first-page":"762320","DOI":"10.1155\/2014\/762320","volume":"2014","author":"N Chaudhry","year":"2014","unstructured":"Chaudhry N, Duggal AK (2014) Sepsis associated encephalopathy. Adv Med 2014:762320","journal-title":"Adv Med"},{"issue":"10","key":"3870_CR6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s11910-013-0383-y","volume":"13","author":"M Ziaja","year":"2013","unstructured":"Ziaja M (2013) Septic encephalopathy. Curr Neurol Neurosci Rep 13(10):383","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"8","key":"3870_CR7","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/00003246-199008000-00001","volume":"18","author":"CL Sprung","year":"1990","unstructured":"Sprung CL, Peduzzi PN, Shatney CH, Schein RM, Wilson MF, Sheagren JN, Hinshaw LB (1990) Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Crit Care Med 18(8):801\u2013806","journal-title":"Crit Care Med"},{"issue":"6","key":"3870_CR8","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jama.1996.03530300054040","volume":"275","author":"LA Eidelman","year":"1996","unstructured":"Eidelman LA, Putterman D, Putterman C, Sprung CL (1996) The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities. JAMA 275(6):470\u2013473","journal-title":"JAMA"},{"issue":"7","key":"3870_CR9","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3390\/cells12071088","volume":"12","author":"B DeWulf","year":"2023","unstructured":"DeWulf B, Minsart L, Verdonk F, Kruys V, Piagnerelli M, Maze M, Saxena S (2023) High mobility group box 1 (HMGB1): potential target in sepsis-associated encephalopathy. Cells 12(7):1088","journal-title":"Cells"},{"issue":"2","key":"3870_CR10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jointm.2021.08.002","volume":"1","author":"Y Huang","year":"2021","unstructured":"Huang Y, Chen R, Jiang L, Li S, Xue Y (2021) Basic research and clinical progress of sepsis-associated encephalopathy. J Intensive Med 1(2):90\u201395","journal-title":"J Intensive Med"},{"issue":"2","key":"3870_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/14787210.2020.1812384","volume":"19","author":"SC Tauber","year":"2021","unstructured":"Tauber SC, Djukic M, Gossner J, Eiffert H, Bruck W, Nau R (2021) Sepsis-associated encephalopathy and septic encephalitis: an update. Expert Rev Anti Infect Ther 19(2):215\u2013231","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"6","key":"3870_CR12","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S1474-4422(14)70017-1","volume":"13","author":"CN Widmann","year":"2014","unstructured":"Widmann CN, Heneka MT (2014) Long-term cerebral consequences of sepsis. Lancet Neurol 13(6):630\u2013636","journal-title":"Lancet Neurol"},{"issue":"1","key":"3870_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00134-007-0934-2","volume":"34","author":"RP Dellinger","year":"2008","unstructured":"Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC et al (2008) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34(1):17\u201360","journal-title":"Intensive Care Med"},{"issue":"1","key":"3870_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/CCM.0b013e3182783b72","volume":"41","author":"J Barr","year":"2023","unstructured":"Barr J, Fraser GL, Puntillo K, Ely EW, Gelinas C, Dasta JF, Davidson JE, Devlin JW et al (2023) Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 41(1):263\u2013306","journal-title":"Crit Care Med"},{"issue":"2","key":"3870_CR15","doi-asserted-by":"publisher","first-page":"R8","DOI":"10.1186\/cc8916","volume":"14","author":"PP Pandharipande","year":"2010","unstructured":"Pandharipande PP, Sanders RD, Girard TD, McGrane S, Thompson JL, Shintani AK, Herr DL, Maze M et al (2010) Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Crit Care 14(2):R8","journal-title":"Crit Care"},{"issue":"26","key":"3870_CR16","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1056\/NEJMoa1904710","volume":"380","author":"Y Shehabi","year":"2019","unstructured":"Shehabi Y, Howe BD, Bellomo R, Arabi YM, Bailey M, Bass FE, Bin Kadiman S, McArthur CJ et al (2019) Early sedation with dexmedetomidine in critically ill patients. N Engl J Med 380(26):2506\u20132517","journal-title":"N Engl J Med"},{"issue":"4","key":"3870_CR17","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1097\/CCM.0b013e3181cc4824","volume":"38","author":"DF Gaieski","year":"2010","unstructured":"Gaieski DF, Mikkelsen ME, Band RA, Pines JM, Massone R, Furia FF, Shofer FS, Goyal M (2010) Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 38(4):1045\u20131053","journal-title":"Crit Care Med"},{"issue":"2","key":"3870_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1001\/jamainternmed.2018.5849","volume":"179","author":"F Fang","year":"2019","unstructured":"Fang F, Zhang Y, Tang J, Lunsford LD, Li T, Tang R, He J, Xu P et al (2019) Association of corticosteroid treatment with outcomes in adult patients with sepsis: a systematic review and meta-analysis. JAMA Intern Med 179(2):213\u2013223","journal-title":"JAMA Intern Med"},{"key":"3870_CR19","doi-asserted-by":"publisher","first-page":"1328729","DOI":"10.1155\/2022\/1328729","volume":"2022","author":"S Pan","year":"2022","unstructured":"Pan S, Lv Z, Wang R, Shu H, Yuan S, Yu Y, Shang Y (2022) Sepsis-Induced brain dysfunction: pathogenesis, diagnosis, and treatment. Oxid Med Cell Longev 2022:1328729","journal-title":"Oxid Med Cell Longev"},{"issue":"7","key":"3870_CR20","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41577-021-00643-7","volume":"22","author":"T Manabe","year":"2022","unstructured":"Manabe T, Heneka MT (2022) Cerebral dysfunctions caused by sepsis during ageing. Nat Rev Immunol 22(7):444\u2013458","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"3870_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.apsb.2019.12.003","volume":"10","author":"C Lv","year":"2020","unstructured":"Lv C, Huang L (2020) Xenobiotic receptors in mediating the effect of sepsis on drug metabolism. Acta Pharm Sin B 10(1):33\u201341","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"3870_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10753-019-01124-9","volume":"43","author":"LG Danielski","year":"2020","unstructured":"Danielski LG, Giustina AD, Bonfante S, Barichello T, Petronilho F (2020) The NLRP3 inflammasome and its role in sepsis development. Inflammation 43(1):24\u201331","journal-title":"Inflammation"},{"issue":"2","key":"3870_CR23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s12640-020-00270-5","volume":"39","author":"M Gu","year":"2021","unstructured":"Gu M, Mei XL, Zhao YN (2021) Sepsis and cerebral dysfunction: BBB damage, neuroinflammation, oxidative stress, apoptosis and autophagy as key mediators and the potential therapeutic approaches. Neurotox Res 39(2):489\u2013503","journal-title":"Neurotox Res"},{"issue":"3","key":"3870_CR24","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s12035-022-03148-z","volume":"60","author":"Y Xin","year":"2023","unstructured":"Xin Y, Tian M, Deng S, Li J, Yang M, Gao J, Pei X, Wang Y et al (2023) The key drivers of brain injury by systemic inflammatory responses after sepsis: microglia and neuroinflammation. Mol Neurobiol 60(3):1369\u20131390","journal-title":"Mol Neurobiol"},{"issue":"3","key":"3870_CR25","doi-asserted-by":"publisher","first-page":"e241","DOI":"10.1097\/CCM.0000000000005307","volume":"50","author":"T Barichello","year":"2022","unstructured":"Barichello T, Generoso JS, Dominguini D, C\u00f3rneo E, Giridharan VV, Sahrapour TA, Sim\u00f5es LR, Rosa MID et al (2022) Postmortem evidence of brain inflammatory markers and injury in septic patients: a systematic review. Critical Care Med 50(3):e241\u2013e252","journal-title":"Critical Care Med"},{"issue":"3","key":"3870_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3390\/medicines6030085","volume":"6","author":"A Yiannikourides","year":"2019","unstructured":"Yiannikourides A, Latunde-Dada GO (2019) A short review of iron metabolism and pathophysiology of iron disorders. Medicines (Basel) 6(3):85","journal-title":"Medicines (Basel)"},{"issue":"2","key":"3870_CR27","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3324\/haematol.2019.232124","volume":"105","author":"C Camaschella","year":"2020","unstructured":"Camaschella C, Nai A, Silvestri L (2020) Iron metabolism and iron disorders revisited in the hepcidin era. Haematologica 105(2):260\u2013272","journal-title":"Haematologica"},{"issue":"9","key":"3870_CR28","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.3390\/ijms22094591","volume":"22","author":"AS Vogt","year":"2021","unstructured":"Vogt AS, Arsiwala T, Mohsen M, Vogel M, Manolova V, Bachmann MF (2021) On iron metabolism and its regulation. Int J Mol Sci 22(9):4591","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3870_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1136\/jcp.2010.086991","volume":"64","author":"M Munoz","year":"2011","unstructured":"Munoz M, Garcia-Erce JA, Remacha AF (2011) Disorders of iron metabolism. Part II: iron deficiency and iron overload. J Clin Pathol 64(4):287\u2013296","journal-title":"J Clin Pathol"},{"key":"3870_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-1-4939-2095-2_10","volume":"844","author":"J Chifman","year":"2014","unstructured":"Chifman J, Laubenbacher R, Torti SV (2014) A systems biology approach to iron metabolism. Adv Exp Med Biol 844:201\u2013225","journal-title":"Adv Exp Med Biol"},{"key":"3870_CR31","doi-asserted-by":"crossref","unstructured":"Sharawy N, Imam AA, Aboulhoda BE, Khalifa MM, Morcos GNB, Abd Algaleel WA, Moustafa PE, Abdelbaset MA et al (2022) Iron dyshomeostasis and time-course changes in iron-uptake systems and ferritin level in relation to pro-inflammatory microglia polarization in sepsis-induced encephalopathy.\u00a0Front Physiol 13:953206","DOI":"10.3389\/fphys.2022.953206"},{"key":"3870_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2021.01.025","volume":"165","author":"Q Liu","year":"2021","unstructured":"Liu Q, Wu J, Zhang X, Wu X, Zhao Y, Ren J (2021) Iron homeostasis and disorders revisited in the sepsis. Free Radical Biol Med 165:1\u201313","journal-title":"Free Radical Biol Med"},{"issue":"11","key":"3870_CR33","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1007\/s11064-007-9375-0","volume":"32","author":"R Dringen","year":"2007","unstructured":"Dringen R, Bishop GM, Koeppe M, Dang TN, Robinson SR (2007) The pivotal role of astrocytes in the metabolism of iron in the brain. Neurochem Res 32(11):1884\u20131890","journal-title":"Neurochem Res"},{"issue":"5","key":"3870_CR34","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1111\/brv.12521","volume":"94","author":"ZM Qian","year":"2019","unstructured":"Qian ZM, Ke Y (2019) Brain iron transport. Biol Rev Camb Philos Soc 94(5):1672\u20131684","journal-title":"Biol Rev Camb Philos Soc"},{"issue":"17","key":"3870_CR35","doi-asserted-by":"publisher","first-page":"8412","DOI":"10.7150\/thno.59092","volume":"11","author":"M Morales","year":"2021","unstructured":"Morales M, Xue X (2021) Targeting iron metabolism in cancer therapy. Theranostics 11(17):8412\u20138429","journal-title":"Theranostics"},{"issue":"4","key":"3870_CR36","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1007\/s12035-016-9879-1","volume":"54","author":"H Jiang","year":"2016","unstructured":"Jiang H, Wang J, Rogers J, Xie J (2016) Brain iron metabolism dysfunction in Parkinson\u2019s disease. Mol Neurobiol 54(4):3078\u20133101","journal-title":"Mol Neurobiol"},{"issue":"13","key":"3870_CR37","doi-asserted-by":"publisher","first-page":"7267","DOI":"10.3390\/ijms23137267","volume":"23","author":"RJ Ward","year":"2022","unstructured":"Ward RJ, Dexter DT, Crichton RR (2022) Iron, neuroinflammation and neurodegeneration. Int J Mol Sci 23(13):7267","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3870_CR38","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00702-010-0470-z","volume":"118","author":"RR Crichton","year":"2011","unstructured":"Crichton RR, Dexter DT, Ward RJ (2011) Brain iron metabolism and its perturbation in neurological diseases. J Neural Transm (Vienna, Austria: 1996) 118(3):301\u201314","journal-title":"J Neural Transm (Vienna, Austria: 1996)"},{"issue":"15","key":"3870_CR39","doi-asserted-by":"publisher","first-page":"5529","DOI":"10.3390\/ijms21155529","volume":"21","author":"A Gonzalez-Dominguez","year":"2020","unstructured":"Gonzalez-Dominguez A, Visiedo-Garcia FM, Dominguez-Riscart J, Gonzalez-Dominguez R, Mateos RM, Lechuga-Sancho AM (2020) Iron metabolism in obesity and metabolic syndrome. Int J Mol Sci 21(15):5529","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3870_CR40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12967-018-1399-5","volume":"16","author":"D Vela","year":"2018","unstructured":"Vela D (2018) Hepcidin, an emerging and important player in brain iron homeostasis. J Transl Med 16(1):25","journal-title":"J Transl Med"},{"issue":"4","key":"3870_CR41","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/cphy.c170045","volume":"8","author":"C Doguer","year":"2018","unstructured":"Doguer C, Ha JH, Collins JF (2018) Intersection of iron and copper metabolism in the mammalian intestine and liver. Compr Physiol 8(4):1433\u20131461","journal-title":"Compr Physiol"},{"issue":"3","key":"3870_CR42","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1042\/BJ20101825","volume":"434","author":"J Wang","year":"2011","unstructured":"Wang J, Pantopoulos K (2011) Regulation of cellular iron metabolism. Biochem J 434(3):365\u2013381","journal-title":"Biochem J"},{"issue":"8","key":"3870_CR43","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3390\/cancers11081077","volume":"11","author":"MS Petronek","year":"2019","unstructured":"Petronek MS, Spitz DR, Buettner GR, Allen BG (2019) Linking cancer metabolic dysfunction and genetic instability through the lens of iron metabolism. Cancers 11(8):1077","journal-title":"Cancers"},{"key":"3870_CR44","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1146\/annurev-nutr-062320-112625","volume":"42","author":"S Dutt","year":"2022","unstructured":"Dutt S, Hamza I, Bartnikas TB (2022) Molecular mechanisms of iron and heme metabolism. Annu Rev Nutr 42:311\u2013335","journal-title":"Annu Rev Nutr"},{"issue":"3","key":"3870_CR45","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.pneurobio.2007.07.009","volume":"83","author":"Y Ke","year":"2007","unstructured":"Ke Y, Qian ZM (2007) Brain iron metabolism: neurobiology and neurochemistry. Prog Neurobiol 83(3):149\u2013173","journal-title":"Prog Neurobiol"},{"issue":"7","key":"3870_CR46","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.ajpath.2021.04.005","volume":"191","author":"SA Bloomer","year":"2021","unstructured":"Bloomer SA, Brown KE (2021) Hepcidin and iron metabolism in experimental liver injury. Am J Pathol 191(7):1165\u20131179","journal-title":"Am J Pathol"},{"issue":"17","key":"3870_CR47","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1016\/j.scib.2021.02.010","volume":"66","author":"Q Mu","year":"2021","unstructured":"Mu Q, Chen L, Gao X, Shen S, Sheng W, Min J, Wang F (2021) The role of iron homeostasis in remodeling immune function and regulating inflammatory disease. Sci Bull (Beijing) 66(17):1806\u20131816","journal-title":"Sci Bull (Beijing)"},{"issue":"2","key":"3870_CR48","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1039\/C4MT00164H","volume":"7","author":"LC Kuhn","year":"2015","unstructured":"Kuhn LC (2015) Iron regulatory proteins and their role in controlling iron metabolism. Metallomics 7(2):232\u2013243","journal-title":"Metallomics"},{"issue":"7","key":"3870_CR49","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.bbadis.2015.03.011","volume":"1852","author":"B Silva","year":"2015","unstructured":"Silva B, Faustino P (2015) An overview of molecular basis of iron metabolism regulation and the associated pathologies. Biochim Biophys Acta 1852(7):1347\u20131359","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"3870_CR50","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrn3453","volume":"14","author":"TA Rouault","year":"2013","unstructured":"Rouault TA (2013) Iron metabolism in the CNS: implications for neurodegenerative diseases. Nat Rev Neurosci 14(8):551\u2013564","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"3870_CR51","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/biof.84","volume":"36","author":"MT N\u00fa\u00f1ez","year":"2010","unstructured":"N\u00fa\u00f1ez MT (2010) Regulatory mechanisms of intestinal iron absorption-uncovering of a fast-response mechanism based on DMT1 and ferroportin endocytosis. BioFactors (Oxford, England) 36(2):88\u201397","journal-title":"BioFactors (Oxford, England)"},{"issue":"7","key":"3870_CR52","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.bbadis.2018.08.030","volume":"1865","author":"H Zhang","year":"2019","unstructured":"Zhang H, Zhabyeyev P, Wang S, Oudit GY (2019) Role of iron metabolism in heart failure: from iron deficiency to iron overload, Biochimica et biophysica acta. Mol Basis Dis 1865(7):1925\u20131937","journal-title":"Mol Basis Dis"},{"issue":"5","key":"3870_CR53","first-page":"447","volume":"83","author":"A Piperno","year":"1998","unstructured":"Piperno A (1998) Classification and diagnosis of iron overload. Haematologica 83(5):447\u2013455","journal-title":"Haematologica"},{"issue":"4","key":"3870_CR54","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1055\/s-2005-923311","volume":"25","author":"EM Brunt","year":"2005","unstructured":"Brunt EM (2005) Pathology of hepatic iron overload. Semin Liver Dis 25(4):392\u2013401","journal-title":"Semin Liver Dis"},{"issue":"4","key":"3870_CR55","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s40629-021-00171-9","volume":"30","author":"F Roth-Walter","year":"2021","unstructured":"Roth-Walter F (2021) Compensating functional iron deficiency in patients with allergies with targeted micronutrition. Allergo Journal International 30(4):130\u2013134","journal-title":"Allergo Journal International"},{"issue":"9","key":"3870_CR56","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.3390\/jcm10092008","volume":"10","author":"M Sandnes","year":"2021","unstructured":"Sandnes M, Ulvik RJ, Vorland M, Reikvam H (2021) Hyperferritinemia-a clinical overview. J Clin Med 10(9):2008","journal-title":"J Clin Med"},{"issue":"8","key":"3870_CR57","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1002\/hep4.2012","volume":"6","author":"CC Hsu","year":"2022","unstructured":"Hsu CC, Senussi NH, Fertrin KY, Kowdley KV (2022) Iron overload disorders. Hepatol Commun 6(8):1842\u20131854","journal-title":"Hepatol Commun"},{"issue":"Suppl 1","key":"3870_CR58","first-page":"S6","volume":"21","author":"S Dev","year":"2017","unstructured":"Dev S, Babitt JL (2017) Overview of iron metabolism in health and disease. Hemodial Int 21(Suppl 1):S6\u2013S20","journal-title":"Hemodial Int"},{"issue":"7","key":"3870_CR59","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1111\/j.1537-2995.2011.03495.x","volume":"52","author":"LT Goodnough","year":"2012","unstructured":"Goodnough LT (2012) Iron deficiency syndromes and iron-restricted erythropoiesis (CME). Transfusion 52(7):1584\u20131592","journal-title":"Transfusion"},{"issue":"1","key":"3870_CR60","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/antiox10010061","volume":"10","author":"PJ Urrutia","year":"2021","unstructured":"Urrutia PJ, B\u00f3rquez DA, N\u00fa\u00f1ez MT (2021) Inflaming the brain with iron. Antioxidants (Basel) 10(1):61","journal-title":"Antioxidants (Basel)"},{"issue":"20","key":"3870_CR61","doi-asserted-by":"publisher","first-page":"7853","DOI":"10.1074\/jbc.RA118.001949","volume":"293","author":"RC McCarthy","year":"2018","unstructured":"McCarthy RC, Sosa JC, Gardeck AM, Baez AS, Lee CH, Wessling-Resnick M (2018) Inflammation-induced iron transport and metabolism by brain microglia. J Biol Chem 293(20):7853\u20137863","journal-title":"J Biol Chem"},{"issue":"8","key":"3870_CR62","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1210\/en.2007-1626","volume":"149","author":"Q Wang","year":"2008","unstructured":"Wang Q, Du F, Qian ZM, Ge XH, Zhu L, Yung WH, Yang L, Ke Y (2008) Lipopolysaccharide induces a significant increase in expression of iron regulatory hormone hepcidin in the cortex and substantia nigra in rat brain. Endocrinology 149(8):3920\u20133925","journal-title":"Endocrinology"},{"key":"3870_CR63","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.nutr.28.061807.155521","volume":"28","author":"MU Muckenthaler","year":"2008","unstructured":"Muckenthaler MU, Galy B, Hentze MW (2008) Systemic iron homeostasis and the iron-responsive element\/iron-regulatory protein (IRE\/IRP) regulatory network. Annu Rev Nutr 28:197\u2013213","journal-title":"Annu Rev Nutr"},{"issue":"5","key":"3870_CR64","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.bbadis.2013.01.021","volume":"1832","author":"J Wang","year":"2013","unstructured":"Wang J, Song N, Jiang H, Wang J, Xie J (2013) Pro-inflammatory cytokines modulate iron regulatory protein 1 expression and iron transportation through reactive oxygen\/nitrogen species production in ventral mesencephalic neurons. Biochim Biophys Acta 1832(5):618\u2013625","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"3870_CR65","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1179\/135100009X392566","volume":"14","author":"C Thomas","year":"2009","unstructured":"Thomas C, Mackey MM, Diaz AA, Cox DP (2009) Hydroxyl radical is produced via the Fenton reaction in submitochondrial particles under oxidative stress: implications for diseases associated with iron accumulation. Redox Rep 14(3):102\u2013108","journal-title":"Redox Rep"},{"issue":"7","key":"3870_CR66","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1164\/rccm.200410-1344OC","volume":"172","author":"LA Callahan","year":"2005","unstructured":"Callahan LA, Supinski GS (2005) Sepsis induces diaphragm electron transport chain dysfunction and protein depletion. Am J Respir Crit Care Med 172(7):861\u2013868","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"3870_CR67","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/ph11040129","volume":"11","author":"IC Nnah","year":"2018","unstructured":"Nnah IC, Wessling-Resnick M (2018) Brain iron homeostasis: a focus on microglial iron. Pharmaceuticals (Basel) 11(4):129","journal-title":"Pharmaceuticals (Basel)"},{"issue":"9\u201310","key":"3870_CR68","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1101\/gad.314674.118","volume":"32","author":"M Conrad","year":"2018","unstructured":"Conrad M, Kagan VE, Bayir H, Pagnussat GC, Head B, Traber MG, Stockwell BR (2018) Regulation of lipid peroxidation and ferroptosis in diverse species. Genes Dev 32(9\u201310):602\u2013619","journal-title":"Genes Dev"},{"issue":"8","key":"3870_CR69","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1097\/CCM.0b013e3181800387","volume":"36","author":"O Huet","year":"2008","unstructured":"Huet O, Cherreau C, Nicco C, Dupic L, Conti M, Borderie D, Pene F, Vicaut E et al (2008) Pivotal role of glutathione depletion in plasma-induced endothelial oxidative stress during sepsis. Crit Care Med 36(8):2328\u20132334","journal-title":"Crit Care Med"},{"issue":"2","key":"3870_CR70","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/jn\/nxx041","volume":"148","author":"TB Aydemir","year":"2018","unstructured":"Aydemir TB, Cousins RJ (2018) The multiple faces of the metal transporter ZIP14 (SLC39A14). J Nutr 148(2):174\u2013184","journal-title":"J Nutr"},{"issue":"5","key":"3870_CR71","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.neuron.2014.07.027","volume":"83","author":"A Kroner","year":"2014","unstructured":"Kroner A, Greenhalgh AD, Zarruk JG, Passos Dos Santos R, Gaestel M, David S (2014) TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord. Neuron 83(5):1098\u20131116","journal-title":"Neuron"},{"key":"3870_CR72","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1146\/annurev-physiol-022516-034406","volume":"79","author":"SA Wolf","year":"2017","unstructured":"Wolf SA, Boddeke HW, Kettenmann H (2017) Microglia in physiology and disease. Annu Rev Physiol 79:619\u2013643","journal-title":"Annu Rev Physiol"},{"issue":"39","key":"3870_CR73","doi-asserted-by":"publisher","first-page":"8364","DOI":"10.1523\/JNEUROSCI.3262-17.2018","volume":"38","author":"C Liu","year":"2018","unstructured":"Liu C, Zhang CW, Lo SQ, Ang ST, Chew KCM, Yu D, Chai BH, Tan B et al (2018) S-nitrosylation of divalent metal transporter 1 enhances iron uptake to mediate loss of dopaminergic neurons and motoric deficit. J Neurosci 38(39):8364\u20138377","journal-title":"J Neurosci"},{"issue":"4","key":"3870_CR74","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/jnc.12244","volume":"126","author":"P Urrutia","year":"2013","unstructured":"Urrutia P, Aguirre P, Esparza A, Tapia V, Mena NP, Arredondo M, Gonz\u00e1lez-Billault C, N\u00fa\u00f1ez MT (2013) Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells. J Neurochem 126(4):541\u2013549","journal-title":"J Neurochem"},{"issue":"14","key":"3870_CR75","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1002\/jnr.21430","volume":"85","author":"N Song","year":"2007","unstructured":"Song N, Jiang H, Wang J, Xie JX (2007) Divalent metal transporter 1 up-regulation is involved in the 6-hydroxydopamine-induced ferrous iron influx. J Neurosci Res 85(14):3118\u20133126","journal-title":"J Neurosci Res"},{"key":"3870_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2021.01.025","volume":"165","author":"Q Liu","year":"2021","unstructured":"Liu Q, Wu J, Zhang X, Wu X, Zhao Y, Ren J (2021) Iron homeostasis and disorders revisited in the sepsis. Free Radic Biol Med 165:1\u201313","journal-title":"Free Radic Biol Med"},{"issue":"6771","key":"3870_CR77","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/35001596","volume":"403","author":"A Donovan","year":"2000","unstructured":"Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw BH, Drejer A et al (2000) Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403(6771):776\u2013781","journal-title":"Nature"},{"issue":"9","key":"3870_CR78","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.bbamcr.2012.01.014","volume":"1823","author":"T Ganz","year":"2012","unstructured":"Ganz T, Nemeth E (2012) Hepcidin and iron homeostasis. Biochim Biophys Acta 1823(9):1434\u20131443","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"3870_CR79","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00018-009-0167-3","volume":"67","author":"SM Wang","year":"2010","unstructured":"Wang SM, Fu LJ, Duan XL, Crooks DR, Yu P, Qian ZM, Di XJ, Li J et al (2010) Role of hepcidin in murine brain iron metabolism. Cell Mol Life Sci 67(1):123\u2013133","journal-title":"Cell Mol Life Sci"},{"key":"3870_CR80","doi-asserted-by":"publisher","first-page":"649640","DOI":"10.3389\/fnut.2021.649640","volume":"8","author":"F Zhang","year":"2021","unstructured":"Zhang F, Zhao P, Qian Z, Zhong M (2021) Central nervous system inflammation induced by lipopolysaccharide up-regulates hepatic hepcidin expression by activating the IL-6\/JAK2\/STAT3 Pathway in Mice. Front Nutr 8:649640","journal-title":"Front Nutr"},{"issue":"3","key":"3870_CR81","doi-asserted-by":"publisher","first-page":"e2676","DOI":"10.1038\/cddis.2017.93","volume":"8","author":"LH You","year":"2017","unstructured":"You LH, Yan CZ, Zheng BJ, Ci YZ, Chang SY, Yu P, Gao GF, Li HY et al (2017) Astrocyte hepcidin is a key factor in LPS-induced neuronal apoptosis. Cell Death Dis 8(3):e2676","journal-title":"Cell Death Dis"},{"issue":"1","key":"3870_CR82","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13024-017-0218-4","volume":"12","author":"ZD Zhou","year":"2017","unstructured":"Zhou ZD, Tan EK (2017) Iron regulatory protein (IRP)-iron responsive element (IRE) signaling pathway in human neurodegenerative diseases. Mol Neurodegener 12(1):75","journal-title":"Mol Neurodegener"},{"issue":"Suppl 1","key":"3870_CR83","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/SHK.0b013e31828fade1","volume":"39","author":"FA Bozza","year":"2013","unstructured":"Bozza FA, D'Avila JC, Ritter C, Sonneville R, Sharshar T, Dal-Pizzol F (2013) Bioenergetics, mitochondrial dysfunction, and oxidative stress in the pathophysiology of septic encephalopathy. Shock 39(Suppl 1):10\u201316","journal-title":"Shock"},{"issue":"1","key":"3870_CR84","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/labinvest.3700691","volume":"88","author":"JC Duvigneau","year":"2008","unstructured":"Duvigneau JC, Piskernik C, Haindl S, Kloesch B, Hartl RT, H\u00fcttemann M, Lee I, Ebel T et al (2008) A novel endotoxin-induced pathway: upregulation of heme oxygenase 1, accumulation of free iron, and free iron-mediated mitochondrial dysfunction. Lab Invest 88(1):70\u201377","journal-title":"Lab Invest"},{"issue":"7","key":"3870_CR85","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.bbagen.2008.09.008","volume":"1790","author":"S Levi","year":"2009","unstructured":"Levi S, Rovida E (2009) The role of iron in mitochondrial function. Biochim Biophys Acta 1790(7):629\u2013636","journal-title":"Biochim Biophys Acta"},{"key":"3870_CR86","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1750-1326-7-29","volume":"7","author":"C Fang","year":"2012","unstructured":"Fang C, Bourdette D, Banker G (2012) Oxidative stress inhibits axonal transport: implications for neurodegenerative diseases. Mol Neurodegener 7:29","journal-title":"Mol Neurodegener"},{"key":"3870_CR87","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fphar.2014.00038","volume":"5","author":"PJ Urrutia","year":"2014","unstructured":"Urrutia PJ, Mena NP, N\u00fa\u00f1ez MT (2014) The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders. Front Pharmacol 5:38","journal-title":"Front Pharmacol"},{"key":"3870_CR88","doi-asserted-by":"publisher","first-page":"809696","DOI":"10.1155\/2011\/809696","volume":"2011","author":"B Lipinski","year":"2011","unstructured":"Lipinski B (2011) Hydroxyl radical and its scavengers in health and disease. Oxid Med Cell Longev 2011:809696","journal-title":"Oxid Med Cell Longev"},{"issue":"9","key":"3870_CR89","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.3390\/antiox12091786","volume":"12","author":"M Sieminski","year":"2023","unstructured":"Sieminski M, Szaruta-Raflesz K, Szypenbejl J, Krzyzaniak K (2023) Potential neuroprotective role of melatonin in sepsis-associated encephalopathy due to its scavenging and anti-oxidative properties. Antioxidants (Basel) 12(9):1786","journal-title":"Antioxidants (Basel)"},{"issue":"2","key":"3870_CR90","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s10753-017-0708-0","volume":"41","author":"MH Ji","year":"2018","unstructured":"Ji MH, Xia DG, Zhu LY, Zhu X, Zhou XY, Xia JY, Yang JJ (2018) Short- and long-term protective effects of melatonin in a mouse model of sepsis-associated encephalopathy. Inflammation 41(2):515\u2013529","journal-title":"Inflammation"},{"issue":"9","key":"3870_CR91","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.bbamcr.2012.05.009","volume":"1823","author":"R Lill","year":"2012","unstructured":"Lill R, Hoffmann B, Molik S, Pierik AJ, Rietzschel N, Stehling O, Uzarska MA, Webert H et al (2012) The role of mitochondria in cellular iron-sulfur protein biogenesis and iron metabolism. Biochim Biophys Acta 1823(9):1491\u20131508","journal-title":"Biochim Biophys Acta"},{"key":"3870_CR92","doi-asserted-by":"publisher","first-page":"854321","DOI":"10.3389\/fmolb.2022.854321","volume":"9","author":"B Ebanks","year":"2022","unstructured":"Ebanks B, Chakrabarti L (2022) Mitochondrial ATP synthase is a target of oxidative stress in neurodegenerative diseases. Front Mol Biosci 9:854321","journal-title":"Front Mol Biosci"},{"issue":"6","key":"3870_CR93","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1097\/CCM.0b013e3181760c4b","volume":"36","author":"JC d'Avila","year":"2008","unstructured":"d'Avila JC, Santiago AP, Am\u00e2ncio RT, Galina A, Oliveira MF, Bozza FA (2008) Sepsis induces brain mitochondrial dysfunction. Crit Care Med 36(6):1925\u20131932","journal-title":"Crit Care Med"},{"key":"3870_CR94","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.mito.2015.02.001","volume":"21","author":"NP Mena","year":"2015","unstructured":"Mena NP, Urrutia PJ, Lourido F, Carrasco CM, N\u00fa\u00f1ez MT (2015) Mitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders. Mitochondrion 21:92\u2013105","journal-title":"Mitochondrion"},{"issue":"3","key":"3870_CR95","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","volume":"26","author":"WS Yang","year":"2016","unstructured":"Yang WS, Stockwell BR (2016) Ferroptosis: death by lipid peroxidation. Trends Cell Biol 26(3):165\u2013176","journal-title":"Trends Cell Biol"},{"key":"3870_CR96","doi-asserted-by":"publisher","first-page":"156078","DOI":"10.1016\/j.cyto.2022.156078","volume":"161","author":"J Wang","year":"2023","unstructured":"Wang J, Yang S, Jing G, Wang Q, Zeng C, Song X, Li X (2023) Inhibition of ferroptosis protects sepsis-associated encephalopathy. Cytokine 161:156078","journal-title":"Cytokine"},{"key":"3870_CR97","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.mehy.2017.02.017","volume":"101","author":"RL Bertrand","year":"2017","unstructured":"Bertrand RL (2017) Iron accumulation, glutathione depletion, and lipid peroxidation must occur simultaneously during ferroptosis and are mutually amplifying events. Med Hypotheses 101:69\u201374","journal-title":"Med Hypotheses"},{"issue":"4","key":"3870_CR98","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/humrep\/deaa363","volume":"36","author":"Y Li","year":"2021","unstructured":"Li Y, Zeng X, Lu D, Yin M, Shan M, Gao Y (2021) Erastin induces ferroptosis via ferroportin-mediated iron accumulation in endometriosis. Hum Reprod 36(4):951\u2013964","journal-title":"Hum Reprod"},{"issue":"29","key":"3870_CR99","doi-asserted-by":"publisher","first-page":"e2202679","DOI":"10.1002\/advs.202202679","volume":"9","author":"W Feng","year":"2022","unstructured":"Feng W, Xiao Y, Zhao C, Zhang Z, Liu W, Ma J, Ganz T, Zhang J et al (2022) New deferric amine compounds efficiently chelate excess iron to treat iron overload disorders and to prevent ferroptosis. Adv Sci (Weinh) 9(29):e2202679","journal-title":"Adv Sci (Weinh)"},{"issue":"4","key":"3870_CR100","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22(4):266\u2013282","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"16","key":"3870_CR101","doi-asserted-by":"publisher","first-page":"9277","DOI":"10.3390\/ijms23169277","volume":"23","author":"Y Lai","year":"2022","unstructured":"Lai Y, Dong J, Wu Y, Zhao L, Wang H, Zhang J, Yao B, Xu X et al (2022) Lipid peroxides mediated ferroptosis in electromagnetic pulse-induced hippocampal neuronal damage via inhibition of GSH\/GPX4 Axis. Int J Mol Sci 23(16):9277","journal-title":"Int J Mol Sci"},{"key":"3870_CR102","doi-asserted-by":"publisher","first-page":"5005136","DOI":"10.1155\/2021\/5005136","volume":"2021","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Song Y, Chen H, Li Q, Gao Y, Lu G, Luo C (2021) Ferroptosis mediated by lipid reactive oxygen species: a possible causal link of neuroinflammation to neurological disorders. Oxid Med Cell Longev 2021:5005136","journal-title":"Oxid Med Cell Longev"},{"key":"3870_CR103","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.freeradbiomed.2022.05.023","volume":"187","author":"J Wang","year":"2022","unstructured":"Wang J, Zhu Q, Wang Y, Peng J, Shao L, Li X (2022) Irisin protects against sepsis-associated encephalopathy by suppressing ferroptosis via activation of the Nrf2\/GPX4 signal axis. Free Radic Biol Med 187:171\u2013184","journal-title":"Free Radic Biol Med"},{"key":"3870_CR104","doi-asserted-by":"crossref","unstructured":"Chu J, Jiang Y, Zhou W, Zhang J, Li H, Yu Y, Yu Y (2022) Acetaminophen alleviates ferroptosis in mice with sepsis-associated encephalopathy via the GPX4 pathway. Hum Exp Toxicol 41:9603271221133548","DOI":"10.1177\/09603271221133547"},{"issue":"1","key":"3870_CR105","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3233\/JAD-2010-1239","volume":"19","author":"MA Smith","year":"2010","unstructured":"Smith MA, Zhu X, Tabaton M, Liu G, McKeel DW, Cohen ML, Wang X, Siedlak SL et al (2010) Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J Alzheimers Dis 19(1):363\u2013372","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"3870_CR106","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s13311-020-00954-y","volume":"18","author":"A Gleason","year":"2021","unstructured":"Gleason A, Bush AI (2021) Iron and ferroptosis as therapeutic targets in Alzheimer\u2019s disease. Neurotherapeutics: J Am Soc Exp NeuroTherapeutics 18(1):252\u2013264","journal-title":"Neurotherapeutics: J Am Soc Exp NeuroTherapeutics"},{"issue":"11","key":"3870_CR107","first-page":"1389","volume":"31","author":"P Yao","year":"2019","unstructured":"Yao P, Chen Y, Li Y, Zhang Y, Qi H, Xu W (2019) Hippocampal neuronal ferroptosis involved in cognitive dysfunction in rats with sepsis-related encephalopathy through the Nrf2\/GPX4 signaling pathway. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 31(11):1389\u20131394","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"issue":"2","key":"3870_CR108","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s11030-018-9878-4","volume":"23","author":"YP Singh","year":"2019","unstructured":"Singh YP, Pandey A, Vishwakarma S, Modi G (2019) A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer\u2019s and Parkinson\u2019 diseases. Mol Divers 23(2):509\u2013526","journal-title":"Mol Divers"},{"issue":"2","key":"3870_CR109","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/ph14020095","volume":"14","author":"J Kosyakovsky","year":"2021","unstructured":"Kosyakovsky J, Fine JM, Frey WH 2nd, Hanson LR (2021) Mechanisms of intranasal deferoxamine in neurodegenerative and neurovascular disease. Pharmaceuticals (Basel) 14(2):95","journal-title":"Pharmaceuticals (Basel)"},{"key":"3870_CR110","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.brainres.2014.05.048","volume":"1574","author":"JM Fine","year":"2014","unstructured":"Fine JM, Forsberg AC, Renner DB, Faltesek KA, Mohan KG, Wong JC, Arneson LC, Crow JM et al (2014) Intranasally-administered deferoxamine mitigates toxicity of 6-OHDA in a rat model of Parkinson\u05f3s disease. Brain Res 1574:96\u2013104","journal-title":"Brain Res"},{"issue":"8753","key":"3870_CR111","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/0140-6736(91)92978-B","volume":"337","author":"DR Crapper McLachlan","year":"1991","unstructured":"Crapper McLachlan DR, Dalton AJ, Kruck TP, Bell MY, Smith WL, Kalow W, Andrews DF (1991) Intramuscular desferrioxamine in patients with Alzheimer\u2019s disease. Lancet 337(8753):1304\u20131308","journal-title":"Lancet"},{"issue":"1","key":"3870_CR112","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41598-021-03981-7","volume":"12","author":"Y Nikaido","year":"2022","unstructured":"Nikaido Y, Midorikawa Y, Furukawa T, Shimoyama S, Takekawa D, Kitayama M, Ueno S, Kushikata T et al (2022) The role of neutrophil gelatinase-associated lipocalin and iron homeostasis in object recognition impairment in aged sepsis-survivor rats. Sci Rep 12(1):249","journal-title":"Sci Rep"},{"issue":"5","key":"3870_CR113","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s11064-021-03262-9","volume":"46","author":"X Zeng","year":"2021","unstructured":"Zeng X, An H, Yu F, Wang K, Zheng L, Zhou W, Bao Y, Yang J et al (2021) Benefits of iron chelators in the treatment of Parkinson\u2019s disease. Neurochem Res 46(5):1239\u20131251","journal-title":"Neurochem Res"},{"issue":"9","key":"3870_CR114","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1097\/01.CCM.0000281452.60683.96","volume":"35","author":"T Barichello","year":"2007","unstructured":"Barichello T, Machado RA, Constantino L, Valvassori SS, R\u00e9us GZ, Martins MR, Petronilho F, Ritter C et al (2007) Antioxidant treatment prevented late memory impairment in an animal model of sepsis. Crit Care Med 35(9):2186\u20132190","journal-title":"Crit Care Med"},{"key":"3870_CR115","doi-asserted-by":"publisher","first-page":"148383","DOI":"10.1016\/j.brainres.2023.148383","volume":"1812","author":"H Jia","year":"2023","unstructured":"Jia H, Liu X, Cao Y, Niu H, Lan Z, Li R, Li F, Sun D et al (2023) Deferoxamine ameliorates neurological dysfunction by inhibiting ferroptosis and neuroinflammation after traumatic brain injury. Brain Res 1812:148383","journal-title":"Brain Res"},{"issue":"1","key":"3870_CR116","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12974-016-0740-2","volume":"13","author":"Y Li","year":"2016","unstructured":"Li Y, Pan K, Chen L, Ning JL, Li X, Yang T, Terrando N, Gu J et al (2016) Deferoxamine regulates neuroinflammation and iron homeostasis in a mouse model of postoperative cognitive dysfunction. J Neuroinflammation 13(1):268","journal-title":"J Neuroinflammation"},{"key":"3870_CR117","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12974-015-0238-3","volume":"12","author":"XY Zhang","year":"2015","unstructured":"Zhang XY, Cao JB, Zhang LM, Li YF, Mi WD (2015) Deferoxamine attenuates lipopolysaccharide-induced neuroinflammation and memory impairment in mice. J Neuroinflammation 12:20","journal-title":"J Neuroinflammation"},{"issue":"2","key":"3870_CR118","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10787-019-00665-7","volume":"28","author":"M Zeinivand","year":"2020","unstructured":"Zeinivand M, Nahavandi A, Zare M (2020) Deferoxamine regulates neuroinflammation and oxidative stress in rats with diabetes-induced cognitive dysfunction. Inflammopharmacology 28(2):575\u2013583","journal-title":"Inflammopharmacology"},{"issue":"2","key":"3870_CR119","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJMct1004810","volume":"364","author":"GM Brittenham","year":"2011","unstructured":"Brittenham GM (2011) Iron-chelating therapy for transfusional iron overload. N Engl J Med 364(2):146\u2013156","journal-title":"N Engl J Med"},{"issue":"22","key":"3870_CR120","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1056\/NEJMra1800219","volume":"379","author":"RC Hider","year":"2018","unstructured":"Hider RC, Hoffbrand AV (2018) The role of deferiprone in iron chelation. N Engl J Med 379(22):2140\u20132150","journal-title":"N Engl J Med"},{"issue":"10","key":"3870_CR121","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1182\/blood.V79.10.2741.bloodjournal79102741","volume":"79","author":"NF Olivieri","year":"1992","unstructured":"Olivieri NF, Koren G, Matsui D, Liu PP, Blendis L, Cameron R, McClelland RA, Templeton DM (1992) Reduction of tissue iron stores and normalization of serum ferritin during treatment with the oral iron chelator L1 in thalassemia intermedia. Blood 79(10):2741\u20132748","journal-title":"Blood"},{"issue":"1","key":"3870_CR122","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1182\/blood-2006-12-065433","volume":"110","author":"N Boddaert","year":"2007","unstructured":"Boddaert N, Le Quan Sang KH, R\u00f6tig A, Leroy-Willig A, Gallet S, Brunelle F, Sidi D, Thalabard J-C et al (2007) Selective iron chelation in Friedreich ataxia: biologic and clinical implications. Blood 110(1):401\u2013408","journal-title":"Blood"},{"issue":"22","key":"3870_CR123","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1056\/NEJMoa2209254","volume":"387","author":"D Devos","year":"2022","unstructured":"Devos D, Labreuche J, Rascol O, Corvol J-C, Duhamel A, Guyon Delannoy P, Poewe W, Compta Y et al (2022) Trial of deferiprone in Parkinson\u2019s disease. N Engl J Med 387(22):2045\u20132055","journal-title":"N Engl J Med"},{"issue":"11","key":"3870_CR124","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.3324\/haematol.2011.043018","volume":"96","author":"G Abbruzzese","year":"2011","unstructured":"Abbruzzese G, Cossu G, Balocco M, Marchese R, Murgia D, Melis M, Galanello R, Barella S et al (2011) A pilot trial of deferiprone for neurodegeneration with brain iron accumulation. Haematologica 96(11):1708\u20131711","journal-title":"Haematologica"},{"issue":"4","key":"3870_CR125","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.stem.2019.09.003","volume":"25","author":"H Nobuta","year":"2019","unstructured":"Nobuta H, Yang N, Ng YH, Marro SG, Sabeur K, Chavali M, Stockley JH, Killilea DW et al (2019) Oligodendrocyte death in Pelizaeus-Merzbacher disease is rescued by iron chelation. Cell Stem Cell 25(4):531-541.e6","journal-title":"Cell Stem Cell"},{"issue":"1","key":"3870_CR126","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1038\/s41598-019-38902-2","volume":"9","author":"M Ramezanpour","year":"2019","unstructured":"Ramezanpour M, Smith JLP, Ooi ML, Gouzos M, Psaltis AJ, Wormald PJ, Vreugde S (2019) Deferiprone has anti-inflammatory properties and reduces fibroblast migration in vitro. Sci Rep 9(1):2378","journal-title":"Sci Rep"},{"issue":"1","key":"3870_CR127","doi-asserted-by":"publisher","first-page":"19630","DOI":"10.1038\/s41598-022-24152-2","volume":"12","author":"A Rayatpour","year":"2022","unstructured":"Rayatpour A, Foolad F, Heibatollahi M, Khajeh K, Javan M (2022) Ferroptosis inhibition by deferiprone, attenuates myelin damage and promotes neuroprotection in demyelinated optic nerve. Sci Rep 12(1):19630","journal-title":"Sci Rep"},{"issue":"2","key":"3870_CR128","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1365-2141.1990.tb07888.x","volume":"76","author":"AN Bartlett","year":"1990","unstructured":"Bartlett AN, Hoffbrand AV, Kontoghiorghes GJ (1990) Long-term trial with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1). II. Clinical observations. Br J Haematol 76(2):301\u2013304","journal-title":"Br J Haematol"},{"issue":"8660","key":"3870_CR129","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0140-6736(89)90641-7","volume":"2","author":"AV Hoffbrand","year":"1989","unstructured":"Hoffbrand AV, Bartlett AN, Veys PA, O'Connor NT, Kontoghiorghes GJ (1989) Agranulocytosis and thrombocytopenia in patient with Blackfan-Diamond anaemia during oral chelator trial. Lancet 2(8660):457","journal-title":"Lancet"},{"key":"3870_CR130","doi-asserted-by":"crossref","unstructured":"Roberts DJ, Brunskill SJ, Doree C, Williams S, Howard J, Hyde CJ (2007) Oral deferiprone for iron chelation in people with thalassaemia. Cochrane Database Syst Rev (3):CD004839","DOI":"10.1002\/14651858.CD004839.pub2"},{"issue":"1","key":"3870_CR131","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.gene.2008.02.016","volume":"415","author":"KB Hilton","year":"2008","unstructured":"Hilton KB, Lambert LA (2008) Molecular evolution and characterization of hepcidin gene products in vertebrates. Gene 415(1):40\u201348","journal-title":"Gene"},{"issue":"5704","key":"3870_CR132","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1126\/science.1104742","volume":"306","author":"E Nemeth","year":"2004","unstructured":"Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306(5704):2090\u20132093","journal-title":"Science"},{"issue":"6108","key":"3870_CR133","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1126\/science.1224577","volume":"338","author":"H Drakesmith","year":"2012","unstructured":"Drakesmith H, Prentice AM (2012) Hepcidin and the iron-infection axis. Science 338(6108):768\u2013772","journal-title":"Science"},{"issue":"7","key":"3870_CR134","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1182\/blood-2005-07-2854","volume":"107","author":"G Dallalio","year":"2006","unstructured":"Dallalio G, Law E, Means RT (2006) Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations. Blood 107(7):2702\u20132704","journal-title":"Blood"},{"issue":"3","key":"3870_CR135","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.tips.2014.01.004","volume":"35","author":"P Ruchala","year":"2014","unstructured":"Ruchala P, Nemeth E (2014) The pathophysiology and pharmacology of hepcidin. Trends Pharmacol Sci 35(3):155\u2013161","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"3870_CR136","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1182\/blood-2010-06-289082","volume":"117","author":"M Poli","year":"2011","unstructured":"Poli M, Girelli D, Campostrini N, Maccarinelli F, Finazzi D, Luscieti S, Nai A, Arosio P (2011) Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo. Blood 117(3):997\u20131004","journal-title":"Blood"},{"key":"3870_CR137","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev-med-043021-032816","volume":"74","author":"E Nemeth","year":"2023","unstructured":"Nemeth E, Ganz T (2023) Hepcidin and iron in health and disease. Annu Rev Med 74:261\u2013277","journal-title":"Annu Rev Med"},{"issue":"18","key":"3870_CR138","doi-asserted-by":"publisher","first-page":"18522","DOI":"10.18632\/aging.103825","volume":"12","author":"Z Deng","year":"2020","unstructured":"Deng Z, Ni J, Wu X, Wei H, Peng J (2020) GPA peptide inhibits NLRP3 inflammasome activation to ameliorate colitis through AMPK pathway. Aging (Albany NY) 12(18):18522\u201318544","journal-title":"Aging (Albany NY)"},{"key":"3870_CR139","doi-asserted-by":"publisher","first-page":"9800794","DOI":"10.1155\/2021\/9800794","volume":"2021","author":"H Zhang","year":"2021","unstructured":"Zhang H, Ostrowski R, Jiang D, Zhao Q, Liang Y, Che X, Zhao J, Xiang X et al (2021) Hepcidin promoted ferroptosis through iron metabolism which is associated with DMT1 signaling activation in early brain injury following subarachnoid hemorrhage. Oxid Med Cell Longev 2021:9800794","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"3870_CR140","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4161\/gmic.1.1.10863","volume":"1","author":"BJ Cherayil","year":"2010","unstructured":"Cherayil BJ (2010) Cross-talk between iron homeostasis and intestinal inflammation. Gut Microbes 1(1):65\u201369","journal-title":"Gut Microbes"},{"issue":"3","key":"3870_CR141","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/MOH.0000000000000236","volume":"23","author":"C-Y Wang","year":"2016","unstructured":"Wang C-Y, Babitt JL (2016) Hepcidin regulation in the anemia of inflammation. Curr Opin Hematol 23(3):189\u2013197","journal-title":"Curr Opin Hematol"},{"issue":"13","key":"3870_CR142","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1158\/1078-0432.CCR-12-3349","volume":"19","author":"R Kurzrock","year":"2013","unstructured":"Kurzrock R, Voorhees PM, Casper C, Furman RR, Fayad L, Lonial S, Borghaei H, Jagannath S et al (2013) A phase I, open-label study of siltuximab, an anti-IL-6 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma, multiple myeloma, or Castleman disease. Clin Cancer Res 19(13):3659\u20133670","journal-title":"Clin Cancer Res"},{"issue":"17","key":"3870_CR143","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1182\/blood-2013-06-505792","volume":"122","author":"KS Cooke","year":"2013","unstructured":"Cooke KS, Hinkle B, Salimi-Moosavi H, Foltz I, King C, Rathanaswami P, Winters A, Steavenson S et al (2013) A fully human anti-hepcidin antibody modulates iron metabolism in both mice and nonhuman primates. Blood 122(17):3054\u20133061","journal-title":"Blood"},{"issue":"5","key":"3870_CR144","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/bcp.13877","volume":"85","author":"M Sheetz","year":"2019","unstructured":"Sheetz M, Barrington P, Callies S, Berg PH, McColm J, Marbury T, Decker B, Dyas GL et al (2019) Targeting the hepcidin-ferroportin pathway in anaemia of chronic kidney disease. Br J Clin Pharmacol 85(5):935\u2013948","journal-title":"Br J Clin Pharmacol"},{"key":"3870_CR145","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.biopha.2018.12.133","volume":"111","author":"M Saeedi","year":"2019","unstructured":"Saeedi M, Eslamifar M, Khezri K, Dizaj SM (2019) Applications of nanotechnology in drug delivery to the central nervous system. Biomed Pharmacother 111:666\u2013675","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"3870_CR146","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/med.21252","volume":"33","author":"P Vlieghe","year":"2013","unstructured":"Vlieghe P, Khrestchatisky M (2013) Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery. Med Res Rev 33(3):457\u2013516","journal-title":"Med Res Rev"},{"issue":"13","key":"3870_CR147","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.2217\/nnm-2018-0139","volume":"13","author":"V Ce\u00f1a","year":"2018","unstructured":"Ce\u00f1a V, J\u00e1tiva P (2018) Nanoparticle crossing of blood-brain barrier: a road to new therapeutic approaches to central nervous system diseases. Nanomedicine (Lond) 13(13):1513\u20131516","journal-title":"Nanomedicine (Lond)"},{"key":"3870_CR148","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.addr.2013.08.008","volume":"71","author":"J Kreuter","year":"2014","unstructured":"Kreuter J (2014) Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? Adv Drug Deliv Rev 71:2","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"3870_CR149","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/wnan.1157","volume":"4","author":"Z Amoozgar","year":"2012","unstructured":"Amoozgar Z, Yeo Y (2012) Recent advances in stealth coating of nanoparticle drug delivery systems. Wiley Interdiscip Rev Nanomed Nanobiotechnol 4(2):219\u2013233","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"5","key":"3870_CR150","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1021\/acsnano.7b08172","volume":"12","author":"L You","year":"2018","unstructured":"You L, Wang J, Liu T, Zhang Y, Han X, Wang T, Guo S, Dong T et al (2018) Targeted brain delivery of rabies virus glycoprotein 29-modified deferoxamine-loaded nanoparticles reverses functional deficits in parkinsonian mice. ACS Nano 12(5):4123\u20134139","journal-title":"ACS Nano"},{"key":"3870_CR151","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jconrel.2019.10.034","volume":"314","author":"SD Hettiarachchi","year":"2019","unstructured":"Hettiarachchi SD, Zhou Y, Seven E, Lakshmana MK, Kaushik AK, Chand HS, Leblanc RM (2019) Nanoparticle-mediated approaches for Alzheimer\u2019 disease pathogenesis, diagnosis, and therapeutics. J Control Release 314:125\u2013140","journal-title":"J Control Release"},{"issue":"3","key":"3870_CR152","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1021\/acs.nanolett.9b04683","volume":"20","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zou Y, Feng C, Lee A, Yin J, Chung R, Park JB, Rizos H et al (2020) Charge conversional biomimetic nanocomplexes as a multifunctional platform for boosting orthotopic glioblastoma RNAi therapy. Nano Lett 20(3):1637\u20131646","journal-title":"Nano Lett"},{"issue":"3","key":"3870_CR153","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jconrel.2013.09.015","volume":"172","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Wang Z, Gemeinhart RA (2013) Progress in microRNA delivery. J Control Release 172(3):962\u2013974","journal-title":"J Control Release"},{"issue":"23\u201324","key":"3870_CR154","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.drudis.2013.07.010","volume":"18","author":"A Angelova","year":"2013","unstructured":"Angelova A, Angelov B, Drechsler M, Lesieur S (2013) Neurotrophin delivery using nanotechnology. Drug Discov Today 18(23\u201324):1263\u20131271","journal-title":"Drug Discov Today"},{"issue":"1","key":"3870_CR155","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1021\/cn400182z","volume":"5","author":"L Xu","year":"2014","unstructured":"Xu L, Zhang H, Wu Y (2014) Dendrimer advances for the central nervous system delivery of therapeutics. ACS Chem Neurosci 5(1):2\u201313","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"3870_CR156","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1465-9921-7-112","volume":"7","author":"DW Lee","year":"2006","unstructured":"Lee DW, Shirley SA, Lockey RF, Mohapatra SS (2006) Thiolated chitosan nanoparticles enhance anti-inflammatory effects of intranasally delivered theophylline. Respir Res 7(1):112","journal-title":"Respir Res"},{"issue":"1","key":"3870_CR157","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12951-021-00796-6","volume":"19","author":"D Di Bella","year":"2021","unstructured":"Di Bella D, Ferreira JPS, Silva RNO, Echem C, Milan A, Akamine EH, Carvalho MH, Rodrigues SF (2021) Gold nanoparticles reduce inflammation in cerebral microvessels of mice with sepsis. J Nanobiotechnology 19(1):52","journal-title":"J Nanobiotechnology"},{"issue":"2","key":"3870_CR158","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1021\/acs.biomac.6b01547","volume":"18","author":"N Wang","year":"2017","unstructured":"Wang N, Jin X, Guo D, Tong G, Zhu X (2017) Iron chelation nanoparticles with delayed saturation as an effective therapy for Parkinson disease. Biomacromol 18(2):461\u2013474","journal-title":"Biomacromol"},{"key":"3870_CR159","doi-asserted-by":"publisher","first-page":"4911205","DOI":"10.1155\/2022\/4911205","volume":"2022","author":"S Entezari","year":"2022","unstructured":"Entezari S, Haghi SM, Norouzkhani N, Sahebnazar B, Vosoughian F, Akbarzadeh D, Islampanah M, Naghsh N et al (2022) Iron chelators in treatment of iron overload. J Toxicol 2022:4911205","journal-title":"J Toxicol"},{"issue":"2","key":"3870_CR160","doi-asserted-by":"publisher","first-page":"352","DOI":"10.4103\/0028-3886.227299","volume":"66","author":"L Moln\u00e1r","year":"2018","unstructured":"Moln\u00e1r L, F\u00fclesdi B, N\u00e9meth N, Moln\u00e1r C (2018) Sepsis-associated encephalopathy: a review of literature. Neurol India 66(2):352\u2013361","journal-title":"Neurol India"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03870-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-023-03870-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03870-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T13:23:40Z","timestamp":1720617820000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-023-03870-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,19]]},"references-count":160,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["3870"],"URL":"https:\/\/doi.org\/10.1007\/s12035-023-03870-2","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,19]]},"assertion":[{"value":"23 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}